Generic Line

In a defeat for generic firm Ranbaxy, the U.S. Court of Appeals for the District of Columbia has upheld a lower federal court’s ruling that said Pfizer is entitled to six months of pediatric exclusivity on its antifungal drug Diflucan (flucanazole).